2-dg

Bajaj Healthcare share price: Bajaj Healthcare soars 11% on receiving DRDO licence to manufacture and market oral Covid drug

Bajaj Healthcare share price: Bajaj Healthcare soars 11% on receiving DRDO licence to manufacture and market oral Covid drug

July 8, 2021

Bajaj Healthcare share price: Bajaj Healthcare soars 11% on receiving DRDO licence to manufacture and market oral Covid drug

Bajaj Healthcare share price: Bajaj Healthcare soars 11% on receiving DRDO licence to manufacture and market oral Covid drug

July 8, 2021

COVID-19 patients: Dr Reddy Labs launches 2-DG oral anti-COVID drug commercially

COVID-19 patients: Dr Reddy Labs launches 2-DG oral anti-COVID drug commercially

June 28, 2021